FDA Decision: FDA accepted Cogent Biosciences’ NDA for bezuclastinib plus sunitinib for previously treated GIST and granted priority review, targeting an FDA action date of Nov. 30, 2026. Ebola Watch (Global): WHO reported 906 suspected Ebola cases in DR Congo, including 223 suspected deaths under investigation, as the outbreak continues to strain response capacity. Ebola Watch (Travel & Policy): The US, Canada, and Mexico announced aligned World Cup travel measures tied to Ebola risk, while CDC expanded entry screening to JFK and other major US airports; Kenya’s high court also blocked a US plan for an Ebola quarantine facility. Ebola Watch (Regional Readiness): Kenya intensified screening at 26 entry points and screened 58,000+ travelers with all suspected cases testing negative so far; Nigeria flagged 21 states as high or moderate importation risk and launched new emergency ambulance assets. Public Health (Vaccines): Boston warned of an mpox uptick and urged vaccination for higher-risk residents. Maternal & Child Health (India): NFHS-6 showed gains in antenatal care, institutional deliveries (to 90.6%), and full child vaccination (to 87.1%). Climate & Health (US): Phoenix confirmed its first heat-related death of 2026, while Houston reported a 329% surge in heat-related ER visits since 2019.